Article ; Online: Nature and Magnitude of the Benefits of Dapagliflozin and Empagliflozin for Heart Failure.
2024 Volume 149, Issue 11, Page(s) 839–842
MeSH term(s) | Humans ; Randomized Controlled Trials as Topic ; Benzhydryl Compounds/therapeutic use ; Heart Failure/drug therapy ; Glucosides |
---|---|
Chemical Substances | empagliflozin (HDC1R2M35U) ; dapagliflozin (1ULL0QJ8UC) ; Benzhydryl Compounds ; Glucosides |
Language | English |
Publishing date | 2024-03-11 |
Publishing country | United States |
Document type | Editorial ; Comment |
ZDB-ID | 80099-5 |
ISSN | 1524-4539 ; 0009-7322 ; 0069-4193 ; 0065-8499 |
ISSN (online) | 1524-4539 |
ISSN | 0009-7322 ; 0069-4193 ; 0065-8499 |
DOI | 10.1161/CIRCULATIONAHA.123.068089 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Ui IV Zs.60: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.